oxidopamine and Ache
oxidopamine has been researched along with Ache in 57 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " Selective degeneration of either peripheral sensory or sympathetic nerve fibers by their respective neurotoxins, capsaicin or 6-hydroxydopamime, significantly reduced the subcutaneous immigration of β-endorphin- (END-) and met-enkephalin- (ENK-)-containing polymorphonuclear leukocytes (PMN) (in the early phase) and mononuclear cells (in the late phase) during painful Freund's complete adjuvant (FCA) rat hind paw inflammation." | 3.76 | Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain. ( Al-Khrasani, M; Brendl, U; Fürst, S; Mousa, SA; Schäfer, M; Shaqura, M, 2010) |
| "A blister model of inflammation in the rat hind footpad was used to study the possible interaction between noradrenergic sympathetic fibres and primary afferent unmyelinated fibres which contain substance P (SP), the putative mediator of neurogenic inflammation." | 3.67 | Sympathetic neurons modulate plasma extravasation in the rat through a non-adrenergic mechanism. ( Helme, RD; Khalil, Z, 1989) |
| "We hypothesized that hyperalgesia of 6-OHDA rats may be related to increased excitability of SDH neurons, and functional change of 5-HT3 receptor may reverse the hyperalgesia of 6-OHDA lesioned rats and decrease cell excitability of SDH neurons." | 1.72 | Inhibition of Spinal 5-HT3 Receptor and Spinal Dorsal Horn Neuronal Excitability Alleviates Hyperalgesia in a Rat Model of Parkinson's Disease. ( An, MQ; Dai, YP; Dong, LG; Gu, HY; Li, CJ; Liu, CF; Liu, LB; Mao, CJ; Wang, F; Zhang, LG, 2022) |
| "Pain is a prevalent PD's non-motor symptom with a higher prevalence of analgesic drugs prescription for patients." | 1.56 | Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease. ( Bortolanza, M; Crivelaro do Nascimento, G; Del Bel, EA; Ferrari, DP; Ferreira-Junior, NC; Guimaraes, FS, 2020) |
| "Although pain is a prevalent nonmotor symptom in Parkinson's disease (PD), it is undertreated, in part because of our limited understanding of the underlying mechanisms." | 1.56 | Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice. ( Cao, JL; Gu, W; Luan, Y; Tang, D; Wu, H; Wu, Y; Xiao, C; Zhou, C, 2020) |
| "Chronic pain is one of the most common non-motor symptoms of Parkinson's disease (PD) affecting up to 85% of patients." | 1.43 | Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease. ( Gee, LE; Pilitsis, JG; Ramirez-Zamora, A; Shin, DS; Walling, I, 2016) |
| "NTP inhibited both tactile allodynia and mechanical and thermal hyperalgesia in a dose-dependent manner." | 1.33 | The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation. ( Li, YH; Mashimo, T; Suzuki, T, 2005) |
| "We conclude that serotonin produces hyperalgesia by a direct action on the primary afferent neuron via the 5-HT1A subset of serotonin receptors." | 1.28 | Serotonin is a directly-acting hyperalgesic agent in the rat. ( Levine, JD; Taiwo, YO, 1992) |
| "A similar neuropathic hyperalgesia, with an associated pain syndrome, is seen in man following peripheral nerve section." | 1.28 | Adjacent neuropathic hyperalgesia in rats: a model for sympathetic independent pain. ( Kingery, WS; Vallin, JA, 1991) |
| "Both baclofen and clonidine were injected intraperitoneally in all experiments." | 1.27 | Role of ascending and descending noradrenergic pathways in the antinociceptive effect of baclofen and clonidine. ( Reid, A; Sawynok, J, 1986) |
Research
Studies (57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (33.33) | 18.7374 |
| 1990's | 14 (24.56) | 18.2507 |
| 2000's | 8 (14.04) | 29.6817 |
| 2010's | 8 (14.04) | 24.3611 |
| 2020's | 8 (14.04) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Sato, F | 1 |
| Nakamura, Y | 1 |
| Ma, S | 1 |
| Kochi, T | 1 |
| Hisaoka-Nakashima, K | 1 |
| Wang, D | 1 |
| Liu, K | 1 |
| Wake, H | 1 |
| Nishibori, M | 1 |
| Morioka, N | 1 |
| Abrishamdar, M | 1 |
| Farbood, Y | 1 |
| Sarkaki, A | 1 |
| Rashno, M | 1 |
| Badavi, M | 1 |
| Bouchatta, O | 1 |
| Aby, F | 1 |
| Sifeddine, W | 2 |
| Bouali-Benazzouz, R | 1 |
| Brochoire, L | 1 |
| Manouze, H | 1 |
| Fossat, P | 1 |
| Ba M'Hamed, S | 1 |
| Bennis, M | 2 |
| Landry, M | 2 |
| Li, CJ | 2 |
| Zhang, LG | 2 |
| Liu, LB | 1 |
| An, MQ | 2 |
| Dong, LG | 2 |
| Gu, HY | 2 |
| Dai, YP | 1 |
| Wang, F | 2 |
| Mao, CJ | 2 |
| Liu, CF | 2 |
| Ba-M'hamed, S | 1 |
| Zhang, JB | 1 |
| Crivelaro do Nascimento, G | 1 |
| Ferrari, DP | 1 |
| Guimaraes, FS | 1 |
| Del Bel, EA | 1 |
| Bortolanza, M | 1 |
| Ferreira-Junior, NC | 1 |
| Luan, Y | 1 |
| Tang, D | 1 |
| Wu, H | 1 |
| Gu, W | 1 |
| Wu, Y | 1 |
| Cao, JL | 1 |
| Xiao, C | 1 |
| Zhou, C | 1 |
| Chen, HS | 1 |
| Li, FP | 1 |
| Li, XQ | 1 |
| Liu, BJ | 1 |
| Qu, F | 1 |
| Wen, WW | 1 |
| Wang, Y | 1 |
| Lin, Q | 1 |
| Li, W | 1 |
| Shi, X | 1 |
| Wang, L | 1 |
| Guo, T | 1 |
| Wei, T | 1 |
| Cheng, K | 1 |
| Rice, KC | 1 |
| Kingery, WS | 2 |
| Clark, JD | 1 |
| da Rocha, JT | 1 |
| Pinton, S | 1 |
| Gai, BM | 1 |
| Nogueira, CW | 1 |
| Gee, LE | 1 |
| Walling, I | 1 |
| Ramirez-Zamora, A | 1 |
| Shin, DS | 1 |
| Pilitsis, JG | 1 |
| Cao, LF | 1 |
| Peng, XY | 1 |
| Huang, Y | 1 |
| Wang, B | 1 |
| Zhou, FM | 1 |
| Cheng, RX | 1 |
| Chen, LH | 1 |
| Luo, WF | 1 |
| Liu, T | 1 |
| Greco, R | 2 |
| Tassorelli, C | 2 |
| Armentero, MT | 2 |
| Sandrini, G | 2 |
| Nappi, G | 2 |
| Blandini, F | 2 |
| Maeda, M | 1 |
| Tsuruoka, M | 1 |
| Hayashi, B | 1 |
| Nagasawa, I | 1 |
| Inoue, T | 1 |
| Mousa, SA | 1 |
| Shaqura, M | 1 |
| Brendl, U | 1 |
| Al-Khrasani, M | 1 |
| Fürst, S | 1 |
| Schäfer, M | 1 |
| Eto, K | 1 |
| Kim, SK | 1 |
| Nabekura, J | 1 |
| Ishibashi, H | 1 |
| Rode, F | 1 |
| Munro, G | 1 |
| Holst, D | 1 |
| Nielsen, EØ | 1 |
| Troelsen, KB | 1 |
| Timmermann, DB | 1 |
| Rønn, LC | 1 |
| Grunnet, M | 1 |
| Baliki, M | 1 |
| Al-Amin, HA | 1 |
| Atweh, SF | 2 |
| Jaber, M | 1 |
| Hawwa, N | 1 |
| Jabbur, SJ | 2 |
| Apkarian, AV | 1 |
| Saadé, NE | 2 |
| Waldron, JB | 1 |
| Sawynok, J | 6 |
| Takeda, R | 1 |
| Ikeda, T | 1 |
| Tsuda, F | 1 |
| Abe, H | 1 |
| Hashiguchi, H | 1 |
| Ishida, Y | 1 |
| Nishimori, T | 1 |
| Suzuki, T | 1 |
| Li, YH | 1 |
| Mashimo, T | 1 |
| Heise, CE | 1 |
| Reyes, S | 1 |
| Mitrofanis, J | 1 |
| Fancellu, R | 1 |
| Bragin, EO | 2 |
| Batueva, NN | 1 |
| Monaenkov, KA | 1 |
| Coderre, TJ | 2 |
| Abbott, FV | 1 |
| Melzack, R | 1 |
| Rodin, BE | 1 |
| Kruger, L | 1 |
| Pappas, B | 1 |
| Ings, R | 2 |
| Roberts, D | 1 |
| Annett, LE | 1 |
| Reading, PJ | 1 |
| Tharumaratnam, D | 1 |
| Abrous, DN | 2 |
| Torres, EM | 1 |
| Dunnett, SB | 1 |
| Ahlgren, SC | 1 |
| Levine, JD | 3 |
| Simon, H | 1 |
| Le Moal, M | 1 |
| Bahuth, NB | 1 |
| Mendlin, A | 1 |
| Martín, FJ | 1 |
| Jacobs, BL | 1 |
| Taiwo, YO | 1 |
| Reid, A | 5 |
| Vallin, JA | 1 |
| Drucker-Colín, R | 1 |
| García-Hernández, F | 1 |
| Mendoza-Ramírez, JL | 1 |
| Pacheco-Cano, MT | 1 |
| Komisaruk, BR | 1 |
| Li, KY | 2 |
| Zhu, JM | 2 |
| Cao, XD | 2 |
| Morgan, MJ | 1 |
| Franklin, KB | 1 |
| Gonzales, R | 1 |
| Goldyne, ME | 1 |
| West, J | 1 |
| Isbrucker, R | 1 |
| Handelmann, GE | 1 |
| Khalil, Z | 1 |
| Helme, RD | 1 |
| Saphier, D | 1 |
| Feldman, S | 1 |
| Danysz, W | 1 |
| Minor, BG | 3 |
| Jonsson, G | 3 |
| Post, C | 3 |
| Archer, T | 3 |
| Pappas, BA | 1 |
| Carey, RJ | 1 |
| Mohammed, AK | 1 |
| Persson, ML | 1 |
| Mantz, J | 1 |
| Milla, C | 1 |
| Glowinski, J | 1 |
| Thierry, AM | 1 |
| Guidobono, F | 1 |
| Netti, C | 1 |
| Sibilia, V | 1 |
| Olgiati, VR | 1 |
| Pecile, A | 1 |
| Ye, ZW | 1 |
| Lou, AL | 1 |
| Zheng, XZ | 1 |
| Peng, JY | 1 |
| Cheng, LY | 1 |
| Bal, HQ | 1 |
| Sun, D | 1 |
| Zuo, HM | 1 |
Reviews
3 reviews available for oxidopamine and Ache
| Article | Year |
|---|---|
Deafferentation in animals as a model for the study of pain: an alternative hypothesis.
Topics: Afferent Pathways; Animals; Capsaicin; Denervation; Disease Models, Animal; Formaldehyde; Hydroxydop | 1984 |
Neuropeptide effects on brain development.
Topics: 5,7-Dihydroxytryptamine; Adrenocorticotropic Hormone; Animals; Animals, Newborn; Behavior, Animal; B | 1985 |
Opioid and catecholaminergic mechanisms of different types of analgesia.
Topics: Acetates; Acetic Acid; Acupuncture Therapy; Analgesia; Animals; Electric Stimulation; Electroshock; | 1986 |
Other Studies
54 other studies available for oxidopamine and Ache
| Article | Year |
|---|---|
Central high mobility group box-1 induces mechanical hypersensitivity with spinal microglial activation in a mouse model of hemi-Parkinson's disease.
Topics: Alarmins; Animals; Antibodies, Neutralizing; Corpus Striatum; Disease Models, Animal; Dopaminergic N | 2022 |
Evaluation of betulinic acid effects on pain, memory, anxiety, catalepsy, and oxidative stress in animal model of Parkinson's disease.
Topics: Animals; Antioxidants; Anxiety; Betulinic Acid; Brain-Derived Neurotrophic Factor; Catalepsy; Diseas | 2023 |
Pain hypersensitivity in a pharmacological mouse model of attention-deficit/hyperactivity disorder.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Gyrus Cinguli; Hyper | 2022 |
Inhibition of Spinal 5-HT3 Receptor and Spinal Dorsal Horn Neuronal Excitability Alleviates Hyperalgesia in a Rat Model of Parkinson's Disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dopamine; Hyperalgesia; Ondansetron; Oxidopamine; P | 2022 |
Effect of atomoxetine on ADHD-pain hypersensitization comorbidity in 6-OHDA lesioned mice.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hy | 2023 |
PACAP/PAC1-R activation contributes to hyperalgesia in 6-OHDA-induced Parkinson's disease model rats via promoting excitatory synaptic transmission of spinal dorsal horn neurons.
Topics: Animals; Extracellular Signal-Regulated MAP Kinases; Humans; Hyperalgesia; Oxidopamine; Pain; Parkin | 2023 |
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
Topics: Amidohydrolases; Analgesics; Animals; Benzamides; Brain; Cannabidiol; Capsaicin; Carbamates; Celecox | 2020 |
Reversal of hyperactive subthalamic circuits differentially mitigates pain hypersensitivity phenotypes in parkinsonian mice.
Topics: Animals; Basal Ganglia; Disease Models, Animal; Dopamine Antagonists; Globus Pallidus; Humans; Hyper | 2020 |
Acute stress regulates nociception and inflammatory response induced by bee venom in rats: possible mechanisms.
Topics: Animals; Bee Venoms; Capsaicin; Disease Models, Animal; Edema; Hindlimb; Hyperalgesia; Inflammation; | 2013 |
Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.
Topics: Adrenergic Agents; Animals; Bufanolides; Complex Regional Pain Syndromes; Disease Models, Animal; Do | 2013 |
Diphenyl diselenide reduces mechanical and thermal nociceptive behavioral responses after unilateral intrastriatal administration of 6-hydroxydopamine in rats.
Topics: Administration, Oral; Animals; Benzene Derivatives; Corpus Striatum; Formaldehyde; Hot Temperature; | 2013 |
Subthalamic deep brain stimulation alters neuronal firing in canonical pain nuclei in a 6-hydroxydopamine lesioned rat model of Parkinson's disease.
Topics: Action Potentials; Adrenergic Agents; Animals; Brain; Deep Brain Stimulation; Disease Models, Animal | 2016 |
Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease.
Topics: Animals; Benzylamines; Corpus Striatum; Disease Models, Animal; Levodopa; Male; Norepinephrine; Oxid | 2016 |
Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia.
Topics: Adrenergic Agents; Animals; Basal Ganglia; Denervation; Dopamine; Formaldehyde; Hyperalgesia; Image | 2008 |
Descending pathways from activated locus coeruleus/subcoeruleus following unilateral hindpaw inflammation in the rat.
Topics: Animals; Carrageenan; Disease Models, Animal; Functional Laterality; Hindlimb; Hyperalgesia; Inflamm | 2009 |
Involvement of the peripheral sensory and sympathetic nervous system in the vascular endothelial expression of ICAM-1 and the recruitment of opioid-containing immune cells to inhibit inflammatory pain.
Topics: Animals; Arthritis, Experimental; Calcitonin Gene-Related Peptide; Capsaicin; Endorphins; Endotheliu | 2010 |
Taltirelin, a thyrotropin-releasing hormone analog, alleviates mechanical allodynia through activation of descending monoaminergic neurons in persistent inflammatory pain.
Topics: Adrenergic Agents; Animals; Biogenic Monoamines; Disease Models, Animal; Dose-Response Relationship, | 2011 |
Positive allosteric modulation of α4β2 nAChR agonist induced behaviour.
Topics: Allosteric Regulation; Animals; Azepines; Corpus Striatum; Female; Male; Nicotinic Agonists; Oxadiaz | 2012 |
Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat.
Topics: Adrenergic Agents; Anesthetics, Local; Animals; Cold Temperature; Disease Models, Animal; Electricit | 2003 |
Peripheral P2X receptors and nociception: interactions with biogenic amine systems.
Topics: Adenosine Triphosphate; Adrenergic Agents; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavio | 2004 |
Unilateral lesions of mesostriatal dopaminergic pathway alters the withdrawal response of the rat hindpaw to mechanical stimulation.
Topics: Adrenergic Agents; Animals; Corpus Striatum; Dopamine; Functional Laterality; Hindlimb; Immunohistoc | 2005 |
The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation.
Topics: 5,7-Dihydroxytryptamine; Analgesics; Animals; Behavior, Animal; Biogenic Monoamines; Hot Temperature | 2005 |
Sensory (nociceptive) stimulation evokes Fos expression in the subthalamus of hemiparkinsonian rats.
Topics: Animals; Cell Count; Disease Models, Animal; Gene Expression Regulation; Male; Neurons; Oncogene Pro | 2008 |
Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Biomarkers; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Hyp | 2007 |
[Role of catecholamine neurons in the reticular lateral nuclei in regulating sensitivity to pain during exposure to reflex stimuli].
Topics: Acupuncture Therapy; Analgesia; Animals; Female; Hydroxydopamines; Male; Oxidopamine; Pain; Rats; Re | 1983 |
Effects of peripheral antisympathetic treatments in the tail-flick, formalin and autotomy tests.
Topics: Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Formaldehyde; Guanethidine; Hot Tempe | 1984 |
Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
Topics: 5,7-Dihydroxytryptamine; Analgesics; Animals; Animals, Newborn; Desipramine; Dihydroxytryptamines; F | 1982 |
Conditioning versus priming of dopaminergic grafts by amphetamine.
Topics: Amphetamine; Animals; Brain; Brain Tissue Transplantation; Conditioning, Psychological; Dopamine; Fe | 1993 |
Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Sympathetic; Hyperalgesia; | 1993 |
Administration of amphetamine does not increase the functional efficacy of dopaminergic grafts made in infancy.
Topics: Amphetamine; Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Conditioning, | 1996 |
Augmentation of nociceptive reflexes and chronic deafferentation pain by chemical lesions of either dopaminergic terminals or midbrain dopaminergic neurons.
Topics: Animals; Behavior, Animal; Chronic Disease; Denervation; Dopamine; Excitatory Amino Acid Agonists; F | 1997 |
Dopaminergic input is required for increases in serotonin output produced by behavioral activation: an in vivo microdialysis study in rat forebrain.
Topics: Animals; Behavior, Animal; Corpus Striatum; Darkness; Dopamine; Dopamine Antagonists; Light; Male; M | 1999 |
Serotonin is a directly-acting hyperalgesic agent in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Dose-Response Relationship, Drug; Hydroxyurea; Hype | 1992 |
Noradrenergic and purinergic involvement in spinal antinociception by 5-hydroxytryptamine and 2-methyl-5-hydroxytryptamine.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Injections, Spinal; Male; Oxidopamine; Pain; | 1991 |
Adjacent neuropathic hyperalgesia in rats: a model for sympathetic independent pain.
Topics: Animals; Disease Models, Animal; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Oxidopamine; P | 1991 |
Possible mechanisms of action of adrenal transplants in Parkinson's disease.
Topics: Adrenal Medulla; Aging; Animals; Apomorphine; Brain Tissue Transplantation; Bucladesine; Caudate Nuc | 1990 |
Effects of destruction of preoptic catecholaminergic nerve terminal on acupuncture analgesia.
Topics: Acupuncture Analgesia; Animals; Dopamine; Evaluation Studies as Topic; Hydroxydopamines; Microscopy, | 1990 |
[Effects of destruction of preoptic catecholaminergic nerve terminals on acupuncture analgesia].
Topics: Acupuncture Analgesia; Adrenergic Fibers; Animals; Catecholamines; Female; Hydroxydopamines; Male; M | 1990 |
6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test.
Topics: Analgesia; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Formaldehyde; Hydroxydopamines; Ma | 1990 |
Noxious stimulus-induced increase in spinal prostaglandin E2 is noradrenergic terminal-dependent.
Topics: Adrenergic Fibers; Animals; Dinoprostone; Hot Temperature; Hydroxydopamines; Norepinephrine; Oxidopa | 1990 |
Adenosine mediates calcium-induced antinociception and potentiation of noradrenergic antinociception in the spinal cord.
Topics: 5,7-Dihydroxytryptamine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Calcium; Drug Synerg | 1990 |
Sympathetic neurons modulate plasma extravasation in the rat through a non-adrenergic mechanism.
Topics: Alprostadil; Animals; Blister; Hydroxydopamines; Inflammation; Male; Neurons; Neurons, Afferent; Neu | 1989 |
Lesions to ascending noradrenergic and serotonergic pathways modify antinociception produced by intracerebroventricular administration of morphine.
Topics: 5,7-Dihydroxytryptamine; Afferent Pathways; Animals; Brain; Cerebral Ventricles; Hydroxydopamines; I | 1989 |
Catecholaminergic projections to tuberoinfundibular neurones of the paraventricular nucleus: II. Effects of stimulation of the ventral noradrenergic ascending bundle: evidence for cotransmission.
Topics: Action Potentials; alpha-Methyltyrosine; Animals; Brain Stem; Electric Stimulation; Hydroxydopamines | 1989 |
Spinal noradrenergic neurotransmission and the analgesia induced by brief footshock.
Topics: Afferent Pathways; Analgesia; Analgesics; Animals; Electroshock; Hydroxydopamines; Injections, Spina | 1986 |
Neonatal 6-hydroxydopamine lesion of spinal noradrenergic terminals: nociception, clonidine analgesia and spinal alpha two adrenoceptors.
Topics: Adrenergic Fibers; Analgesics; Animals; Clonidine; Hydroxydopamines; Norepinephrine; Oxidopamine; Pa | 1987 |
Acute ipsilateral hyperalgesia and chronic contralateral hypoalgesia after unilateral 6-hydroxydopamine lesions of the substantia nigra.
Topics: Animals; Differential Threshold; Dopamine; Electroshock; Escape Reaction; Foot; Hydroxydopamines; Ma | 1986 |
Role of ascending and descending noradrenergic pathways in the antinociceptive effect of baclofen and clonidine.
Topics: Afferent Pathways; Animals; Baclofen; Central Nervous System; Clonidine; Efferent Pathways; Hydroxyd | 1986 |
5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzylamines; Central Nervous System; Hydroxydopamines; Male; Meth | 1986 |
Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
Topics: Analgesia; Animals; Brain; Dopamine; Efferent Pathways; Hydroxydopamines; Locus Coeruleus; Male; Med | 1987 |
Intrathecal noradrenaline restores 5-methoxy-N,N-dimethyltryptamine induced antinociception abolished by intrathecal 6-hydroxydopamine.
Topics: 5,7-Dihydroxytryptamine; Analgesics; Animals; Dopamine; Hydroxydopamines; Injections, Spinal; Male; | 1988 |
Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex.
Topics: alpha-Methyltyrosine; Animals; Cerebral Cortex; Dopamine; Electric Stimulation; Evoked Potentials; H | 1988 |
Role of catecholamines in calcitonin-induced analgesia.
Topics: Analgesics; Animals; Atenolol; Calcitonin; Catecholamines; Hydroxydopamines; Injections, Intraventri | 1985 |
[The effect of the injection of 6-hydroxydopamine intraperitoneally on acupuncture analgesia].
Topics: Acupuncture Therapy; Animals; Electric Stimulation Therapy; Hydroxydopamines; Injections, Intraperit | 1985 |